JW Shinyak

JW Shinyak is a South Korean pharmaceutical company and a key subsidiary of JW Holdings. The company specializes in the development, manufacturing, and marketing of ethical (ETC) and over-the-counter (OTC) drugs, maintaining a dominant market position in dermatology, urology, and otolaryngology. Its product portfolio is particularly well-known for hair loss treatments, including the finasteride-based Monad and dutasteride-based Monaland. Through its subsidiary JW CreaGene, the company also explores advanced biotechnology, specifically dendritic cell-based immunotherapies for various cancers. JW Shinyak continues to expand its presence in the aesthetics and healthcare markets through strategic partnerships and a robust distribution network.